G L Vega - JoVE Visualize

Showing results (61-70 of 91) with videos related to

Pageof 10

Sort By:

The American Journal of Cardiology|May 1, 1997

Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemiaJ M Mostaza, I Schulz, G L Vega, et al.

Journal of Internal Medicine|June 17, 1998

Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissueJ M Mostaza, G L Vega, P Snell, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemiaF Tatò, G L Vega, A R Tall, et al.

Archives of Internal Medicine|April 11, 1994

Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white menR J Valentine, P A Grayburn, G L Vega, et al.

Metabolism: Clinical and Experimental|March 1, 1987

Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.

Nutrition & Diabetes|July 19, 2016

Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart StudyI J Neeland, S M Grundy, X Li, et al.

Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1993

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemiaS H Gianturco, W A Bradley, S Nozaki, et al.

Journal of Lipid Research|April 11, 1992

A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemiaR V Farese, A Garg, V R Pierotti, et al.

Atherosclerosis|October 1, 1990

Influence of lovastatin on concentrations and composition of lipoprotein subfractionsS Nozaki, G L Vega, R J Haddox, et al.

Archives of Internal Medicine|May 27, 1996

Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levelsR Martin-Jadraque, F Tato, J M Mostaza, et al.

Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:

Pageof 10

The American Journal of Cardiology|May 1, 1997

Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemiaJ M Mostaza, I Schulz, G L Vega, et al.

Journal of Internal Medicine|June 17, 1998

Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissueJ M Mostaza, G L Vega, P Snell, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 1995

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemiaF Tatò, G L Vega, A R Tall, et al.

Archives of Internal Medicine|April 11, 1994

Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white menR J Valentine, P A Grayburn, G L Vega, et al.

Metabolism: Clinical and Experimental|March 1, 1987

Low-density lipoprotein metabolism in cerebrotendinous xanthomatosisC M Ballantyne, G L Vega, C East, et al.

Nutrition & Diabetes|July 19, 2016

Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart StudyI J Neeland, S M Grundy, X Li, et al.

Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|April 1, 1993

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemiaS H Gianturco, W A Bradley, S Nozaki, et al.

Journal of Lipid Research|April 11, 1992

A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemiaR V Farese, A Garg, V R Pierotti, et al.

Atherosclerosis|October 1, 1990

Influence of lovastatin on concentrations and composition of lipoprotein subfractionsS Nozaki, G L Vega, R J Haddox, et al.

Archives of Internal Medicine|May 27, 1996

Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levelsR Martin-Jadraque, F Tato, J M Mostaza, et al.

Pageof 10